WaferGen Biosystems

www.wafergen.com

NOW PART OF TAKARA BIO USA, INC. -- Please visit the Takara Bio USA, Inc. company page for the latest updates: https://www.linkedin.com/company-beta/17509/ WaferGen automation systems include innovative genomic technology solutions for single-cell analysis and clinical research. The ICELL8® Single-Cell System is a revolutionary platform which can isolate thousands of single cells and enables selection and processing of specific cells for various analysis methods, including next generation sequencing. The system has demonstrated unbiased isolation of up to 1,800 single cells 5–100 µm in size on a single chip, including cells from solid tumors and brain tissues, pulmonary airway cells, and multiple cell lines. The SmartChip™ platform can be used for profiling and validating molecular biomarkers, and can perform massively parallel singleplex PCR for one-step NGS library preparation in clinical applications. The Apollo™ 324 system can be used to process DNA and RNA obtained from clinical samples into NGS-ready libraries. These technologies offer a powerful set of tools for biological analysis at the molecular and single-cell levels in the life sciences, pharmaceutical, and clinical laboratory industries.

Read more

Reach decision makers at WaferGen Biosystems

Lusha Magic

Free credit every month!

NOW PART OF TAKARA BIO USA, INC. -- Please visit the Takara Bio USA, Inc. company page for the latest updates: https://www.linkedin.com/company-beta/17509/ WaferGen automation systems include innovative genomic technology solutions for single-cell analysis and clinical research. The ICELL8® Single-Cell System is a revolutionary platform which can isolate thousands of single cells and enables selection and processing of specific cells for various analysis methods, including next generation sequencing. The system has demonstrated unbiased isolation of up to 1,800 single cells 5–100 µm in size on a single chip, including cells from solid tumors and brain tissues, pulmonary airway cells, and multiple cell lines. The SmartChip™ platform can be used for profiling and validating molecular biomarkers, and can perform massively parallel singleplex PCR for one-step NGS library preparation in clinical applications. The Apollo™ 324 system can be used to process DNA and RNA obtained from clinical samples into NGS-ready libraries. These technologies offer a powerful set of tools for biological analysis at the molecular and single-cell levels in the life sciences, pharmaceutical, and clinical laboratory industries.

Read more
icon

Country

icon

State

California

icon

City (Headquarters)

Fremont

icon

Estimated Revenue

$5,000,000 to $10,000,000

icon

Social

  • icon
  • icon

Employees statistics

View all employees

Potential Decision Makers

  • Senior Vice President Engineering

    Email ****** @****.com
    Phone (***) ****-****
  • Vice President , Engineering

    Email ****** @****.com
    Phone (***) ****-****
  • Vice President Sales Support

    Email ****** @****.com
    Phone (***) ****-****
  • Vice President

    Email ****** @****.com
    Phone (***) ****-****

Technologies

(42)

Reach decision makers at WaferGen Biosystems

Free credits every month!

My account

WaferGen Biosystems FAQ

Sign up now to uncover all the contact details